Steward Partners Investment Advisory’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Steward Partners Investment Advisory’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-414	Closed	–	–	3498
2022 Q3	$0	Hold	414	–	–	﹤0.01%	3479
2022 Q2	$0	Hold	414	–	–	﹤0.01%	3454
2022 Q1	$0	Buy	414 +14	+4%	+$25	﹤0.01%	3435
2021 Q4	$1K	Hold	400	–	–	﹤0.01%	3158
2021 Q3	$1K	Buy	400 +150	+60%	+$534	﹤0.01%	3128
2021 Q2	$1K	Hold	250	–	–	﹤0.01%	7013
2021 Q1	$1.27K	Buy	+250	New	+$1.3K	﹤0.01%	3289

Steward Partners Investment Advisory's AGTC Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 414 shares.

Steward Partners Investment Advisory first reported a position in AGTC in Q1 2021 and held it in 7 quarters. The position peaked at $1.27K in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

Steward Partners Investment Advisory reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
Steward Partners Investment Advisory sold 414 Applied Genetic Technologies Corporation shares in Q4 2022.
Steward Partners Investment Advisory first reported a position in Applied Genetic Technologies Corporation in Q1 2021 and held it in 7 quarters.
Steward Partners Investment Advisory's Applied Genetic Technologies Corporation position peaked at $1.27K in Q1 2021.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.